These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Effect of penicillamine and zinc on iron metabolism in Wilson's disease. Author: Medici V, Di Leo V, Lamboglia F, Bowlus CL, Tseng SC, D'IncĂ R, Irato P, Burra P, Martines D, Sturniolo GC. Journal: Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470. Abstract: OBJECTIVE: The physiology of iron metabolism in Wilson's disease is largely unknown, and there is a paucity of data on the real presence and progression of iron accumulation. The purpose of this study was to assess the iron metabolism parameters, including hepatic iron concentration, in follow-up liver biopsies and serum, and urinary pro-hepcidin. MATERIAL AND METHODS: Twenty-three Wilson's disease patients undergoing long-term treatment were enrolled in the study. RESULTS: Hepatic iron content was significantly increased in penicillamine-treated patients compared with zinc-treated patients. Serum and urinary pro-hepcidin concentrations were significantly higher in Wilson's disease patients than in healthy volunteers, despite a normal biochemical pattern of iron metabolism. CONCLUSIONS: Long-term penicillamine treatment seems to be responsible for a more marked iron accumulation in the liver. This observation may justify a revision of long-term Wilson's disease treatment modalities with penicillamine. The finding that serum and urinary pro-hepcidin is significantly increased in Wilson's disease patients compared with healthy volunteers suggests a role for hepcidin in iron metabolism in Wilson's disease, but this needs to be confirmed by a study of hepatic hepcidin expression in these patients.[Abstract] [Full Text] [Related] [New Search]